Newly approved integrase inhibitors for clinical treatment of AIDS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Newly approved integrase inhibitors for clinical treatment of AIDS

Published:2014-10 Issue:8 Volume:68 Page:917-921
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Gu Wan-Gang

Funder

National Natural Science Foundation of China

United Foundation of Guizhou (Qiankehe J LKZ[2013]21)

Incubation Project for 2011 Collaborative Innovation Center for Tuberculosis Prevention and Cure in Guizhou Province

Zunyi Medical University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference71 articles.

1. Surveillance for AIDS and HIV infection among black and Hispanic children and women of childbearing age 1981–1989;Gayle;MMWR Surveill Summ,1990

2. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients;McCutchan;AIDS,2007

3. (MK-0518): an integrase inhibitor for the treatment of HIV-1;Evering;Drugs Today,2007

4. Elvitegravir: a once-daily inhibitor of HIV-1 integrase;Wills;Expert Opin Investig Drugs,2012

5. Dolutegravir: a new integrase strand transfer inhibitor for the treatment of HIV;Shah;Pharmacotherapy,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors Associated with Medication Adherence in HIV/AIDS Patients;Korean Journal of Clinical Pharmacy;2023-12-31

2. Spotlight on 4‐substituted quinolines as potential anti‐infective agents: Journey beyond chloroquine;Archiv der Pharmazie;2022-12-09

3. HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities;International Immunopharmacology;2021-06

4. Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents;IRAN J PHARM RES;2021

5. Alkol ve uyuşturucu madde bağımlıları tedavi merkezinde hepatit ve HIV enfeksiyonlarının taranması;Pamukkale Medical Journal;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3